EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives

Magdalena Łyko iD, Anna Ryguła, Michał Kowalski, Julia Karska iD, Alina Jankowska-Konsur iD

International Journal of Molecular Sciences · 19.02.2024 · 25 (4) · 2440

DOI: 10.3390/ijms25042440 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.02.2024. Verfasst von Magdalena Łyko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland. Hauptthemen laut MEDLINE: Pyoderma Gangrenosum, Biological Products. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyoderma gangrenosum (PG) is an uncommon inflammatory dermatological disorder characterized by painful ulcers that quickly spread peripherally. The pathophysiology of PG is not fully understood; however, it is most commonly considered a disease in the spectrum of neutrophilic dermatoses. The treatment of PG remains challenging due to the lack of generally accepted therapeutic guidelines. Existing therapeutic methods focus on limiting inflammation through the use of immunosuppressive and immunomodulatory therapies. Recently, several reports have indicated the successful use of biologic drugs and small molecules administered for coexisting diseases, resulting in ulcer healing. In this review, we summarize the discoveries regarding the pathophysiology of PG and present treatment options to raise awareness and improve the management of this rare entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyoderma GangrenosumBiological ProductsHumansImmunosuppressive AgentsInflammationImmunomodulation

Stichwörter der Autor:innen

biologic drugsimmunosuppressionnew therapiespathophysiologypyoderma gangrenosumtreatment

Substanzen

Immunosuppressive AgentsBiological Products

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Student Research Group of Experimental Dermatology, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland.

ORCID-Profile: Magdalena Łyko, Julia Karska, Alina Jankowska-Konsur

Förderung

  • Wroclaw Medical University

Zitieren

APA

Łyko, M., Ryguła, A., Kowalski, M., Karska, J., & Jankowska-Konsur, A. (2024). The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives. International Journal of Molecular Sciences, 25(4), 2440. https://doi.org/10.3390/ijms25042440

Vancouver

Łyko M, Ryguła A, Kowalski M, Karska J, Jankowska-Konsur A. The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives. International Journal of Molecular Sciences. 2024;25(4):2440. doi:10.3390/ijms25042440

BibTeX
@article{yko2024,
  author = {Łyko, Magdalena and Ryguła, Anna and Kowalski, Michał and Karska, Julia and Jankowska-Konsur, Alina},
  title = {The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {4},
  pages = {2440},
  doi = {10.3390/ijms25042440}
}
Kostenlos starten →